灰色富尔文的抗瘤特性及其毒性
Nanqiong Yu1, Yixiao Fu1, Qingkui Fan1
1Key Laboratory of Environmental Related Diseases and One Health, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, China.
Frontiers in pharmacology
|September 24, 2024
概括
抗真菌抗生素格里索富尔文 (GF) 显示出有前途的抗瘤潜力和多种药理学效果. 本综述全面分析了GF的综合性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 自然产品 化学 化学
背景情况:
- 格里索富尔文 (GF) 是一种耐热,含的抗真菌抗生素,来源于*Penicillium griseofulvum*.
- GF表现出广泛的药理活性,包括抗炎,抗真菌,抗病毒和抗瘤作用.
- 最近的注意力集中在GF的抗瘤特性上,归因于其天然起源,可负担性和多功能性.
研究的目的:
- 综合审查格里索富尔文 (GF) 和其衍生物的抗瘤潜力和毒性.
- 巩固现有的关于GF在癌症背景下的药理学活动的文献.
- 为未来的研究和药物开发提供基础,以针对GF的抗瘤活动.
主要方法:
- 用主要的科学数据库进行文献搜索,包括PubMed和Web of Science.
- 系统审查和分析已发表的关于Griseofulvin药理作用的研究,重点关注抗瘤活性.
- 评估GF衍生物的抗瘤潜力和相关的毒理学概况.
主要成果:
- 格里索富尔文在各种癌症类型中显示出显著的抗瘤潜力.
- 研究表明,GF抗癌作用的基础是不同的机制.
- 目前正在研究GF及其衍生物的毒性概况,以确保治疗安全.
结论:
- 格里索富尔文 (Griseofulvin) 是一种有前途的天然化合物,用于抗癌药物开发.
- 需要进一步的研究,以充分阐明GF的抗瘤机制,并优化其治疗应用.
- 对GF的疗效和安全性概况的全面了解对于其临床转化至关重要.
更多相关视频
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


